Ward VK - Search Results

1

Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.

Win SJ, Ward VK, Dunbar PR, Young SL, Baird MA. Win SJ, et al. Among authors: ward vk. Immunol Cell Biol. 2011 Aug;89(6):681-8. doi: 10.1038/icb.2010.161. Epub 2011 Jan 11. Immunol Cell Biol. 2011. PMID: 21221122

2

Transcutaneous vaccination with virus-like particles.

Young SL, Wilson M, Wilson S, Beagley KW, Ward V, Baird MA. Young SL, et al. Vaccine. 2006 Jun 29;24(26):5406-12. doi: 10.1016/j.vaccine.2006.03.052. Epub 2006 Mar 30. Vaccine. 2006. PMID: 16621190

3

Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation.

Peacey M, Wilson S, Baird MA, Ward VK. Peacey M, et al. Among authors: ward vk. Biotechnol Bioeng. 2007 Dec 1;98(5):968-77. doi: 10.1002/bit.21518. Biotechnol Bioeng. 2007. PMID: 17546687

4

Delivery of vaccine peptides by rapid conjugation to baculovirus particles.

Wilson S, Baird M, Ward VK. Wilson S, et al. Among authors: ward vk. Vaccine. 2008 May 12;26(20):2451-6. doi: 10.1016/j.vaccine.2008.03.027. Epub 2008 Apr 3. Vaccine. 2008. PMID: 18417258

5

Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response.

Peacey M, Wilson S, Perret R, Ronchese F, Ward VK, Young V, Young SL, Baird MA. Peacey M, et al. Among authors: ward vk. Vaccine. 2008 Oct 3;26(42):5334-7. doi: 10.1016/j.vaccine.2008.07.074. Epub 2008 Aug 14. Vaccine. 2008. PMID: 18706958

6

Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles.

Win SJ, McMillan DG, Errington-Mais F, Ward VK, Young SL, Baird MA, Melcher AA. Win SJ, et al. Among authors: ward vk. Br J Cancer. 2012 Jan 3;106(1):92-8. doi: 10.1038/bjc.2011.538. Epub 2011 Dec 1. Br J Cancer. 2012. PMID: 22134504 Free PMC article.

7

Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses.

McKee SJ, Young VL, Clow F, Hayman CM, Baird MA, Hermans IF, Young SL, Ward VK. McKee SJ, et al. Among authors: ward vk. J Control Release. 2012 May 10;159(3):338-45. doi: 10.1016/j.jconrel.2012.02.015. Epub 2012 Feb 22. J Control Release. 2012. PMID: 22386518

8

Antigen incorporated in virus-like particles is delivered to specific dendritic cell subsets that induce an effective antitumor immune response in vivo.

Li K, Peers-Adams A, Win SJ, Scullion S, Wilson M, Young VL, Jennings P, Ward VK, Baird MA, Young SL. Li K, et al. Among authors: ward vk. J Immunother. 2013 Jan;36(1):11-9. doi: 10.1097/CJI.0b013e3182787f5e. J Immunother. 2013. PMID: 23211625

9

An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.

Jemon K, Young V, Wilson M, McKee S, Ward V, Baird M, Young S, Hibma M. Jemon K, et al. PLoS One. 2013 Jun 14;8(6):e66866. doi: 10.1371/journal.pone.0066866. Print 2013. PLoS One. 2013. PMID: 23799135 Free PMC article.

10

Characterization of the chemokine response of RAW264.7 cells to infection by murine norovirus.

Waugh E, Chen A, Baird MA, Brown CM, Ward VK. Waugh E, et al. Among authors: ward vk. Virus Res. 2014 Mar 6;181:27-34. doi: 10.1016/j.virusres.2013.12.025. Epub 2013 Dec 24. Virus Res. 2014. PMID: 24374268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters